Gene expression profiling of fibroblasts in a family withLMNA-related cardiomyopathy reveals molecular pathways implicated in disease pathogenesis

被引:7
作者
Widyastuti, Halida P. [1 ,2 ]
Norden-Krichmar, Trina M. [3 ]
Grosberg, Anna [4 ,5 ]
Zaragoza, Michael V. [1 ,2 ]
机构
[1] Univ Calif Irvine, Sch Med, UCI Cardiogen Program, Dept Pediat,Div Genet & Genom, 2042 Hewitt Hall, Irvine, CA 92697 USA
[2] Univ Calif Irvine, Sch Med, Dept Biol Chem, 2042 Hewitt Hall, Irvine, CA 92697 USA
[3] Univ Calif Irvine, Sch Med, Dept Epidemiol, 3062 Anteater Instruct & Res Bldg, Irvine, CA 92697 USA
[4] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA
[5] Univ Calif Irvine, Edwards Lifesci Ctr Adv Cardiovasc Technol, Irvine, CA USA
关键词
LMNAgene; Lamin; Laminopathies; Cardiomyopathy; RNA sequencing; IGFBP5gene; Fibroblasts; Gene expression; Signaling pathway; LAMIN A/C GENE; NUCLEAR-ENVELOPE ALTERATIONS; DREIFUSS MUSCULAR-DYSTROPHY; DILATED CARDIOMYOPATHY; ATRIOVENTRICULAR-BLOCK; PARTIAL LIPODYSTROPHY; CONDUCTION-SYSTEM; LMNA MUTATIONS; STEM-CELLS; PROTEIN;
D O I
10.1186/s12881-020-01088-w
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Intermediate filament proteins that construct the nuclear lamina of a cell include the Lamin A/C proteins encoded by theLMNAgene, and are implicated in fundamental processes such as nuclear structure, gene expression, and signal transduction.LMNAmutations predominantly affect mesoderm-derived cell lineages in diseases collectively termed as laminopathies that include dilated cardiomyopathy with conduction defects, different forms of muscular dystrophies, and premature aging syndromes as Hutchinson-Gilford Progeria Syndrome. At present, our understanding of the molecular mechanisms regulating tissue-specific manifestations of laminopathies are still limited. Methods To gain deeper insight into the molecular mechanism of a novelLMNAsplice-site mutation (c.357-2A > G) in an affected family with cardiac disease, we conducted deep RNA sequencing and pathway analysis for nine fibroblast samples obtained from three patients with cardiomyopathy, three unaffected family members, and three unrelated, unaffected individuals. We validated our findings by quantitative PCR and protein studies. Results We identified eight significantly differentially expressed genes between the mutant and non-mutant fibroblasts, that included downregulated insulin growth factor binding factor protein 5 (IGFBP5) in patient samples. Pathway analysis showed involvement of the ERK/MAPK signaling pathway consistent with previous studies. We found no significant differences in gene expression for Lamin A/C and B-type lamins between the groups. In mutant fibroblasts, RNA-seq confirmed that only theLMNAwild type allele predominately was expressed, and Western Blot showed normal Lamin A/C protein levels. Conclusions IGFBP5may contribute in maintaining signaling pathway homeostasis, which may lead to the absence of notable molecular and structural abnormalities in unaffected tissues such as fibroblasts. Compensatory mechanisms from other nuclear membrane proteins were not found. Our results also demonstrate that only one copy of the wild type allele is sufficient for normal levels of Lamin A/C protein to maintain physiological function in an unaffected cell type. This suggests that affected cell types such as cardiac tissues may be more sensitive to haploinsufficiency of Lamin A/C. These results provide insight into the molecular mechanism of disease with a possible explanation for the tissue specificity ofLMNA-related dilated cardiomyopathy.
引用
收藏
页数:12
相关论文
共 84 条
  • [1] Global signatures of protein and mRNA expression levels
    Abreu, Raquel de Sousa
    Penalva, Luiz O.
    Marcotte, Edward M.
    Vogel, Christine
    [J]. MOLECULAR BIOSYSTEMS, 2009, 5 (12) : 1512 - 1526
  • [2] The LMNA mutation p.Arg321Ter associated with dilated cardiomyopathy leads to reduced expression and a skewed ratio of lamin A and lamin C proteins
    Al-Saaidi, Rasha
    Rasmussen, Torsten B.
    Palmfeldt, Johan
    Nissen, Peter H.
    Beqqali, Abdelaziz
    Hansen, Jakob
    Pinto, Yigal M.
    Boesen, Thomas
    Mogensen, Jens
    Bross, Peter
    [J]. EXPERIMENTAL CELL RESEARCH, 2013, 319 (19) : 3010 - 3019
  • [3] Autosomal dominant dilated cardiomyopathy with atrioventricular block: A lamin A/C defect-related disease
    Arbustini, E
    Pilotto, A
    Repetto, A
    Grasso, M
    Negri, A
    Diegoli, M
    Campana, C
    Scelsi, L
    Baldini, E
    Gavazzi, A
    Tavazzi, L
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (06) : 981 - 990
  • [4] High incidence of sudden death with conduction system and myocardial disease due to lamins A and C gene mutation
    Bécane, HM
    Bonne, G
    Varnous, S
    Muchir, A
    Ortega, V
    Hammouda, E
    Urtizberea, JA
    Lavergne, T
    Fardeau, M
    Eymard, B
    Weber, S
    Schwartz, K
    Duboc, D
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2000, 23 (11): : 1661 - 1666
  • [5] Bonne G, 2000, ANN NEUROL, V48, P170, DOI 10.1002/1531-8249(200008)48:2<170::AID-ANA6>3.0.CO
  • [6] 2-J
  • [7] Current insights into LMNA cardiomyopathies: Existing models and missing LINCs
    Brayson, Daniel
    Shanahan, Catherine M.
    [J]. NUCLEUS, 2017, 8 (01) : 17 - 33
  • [8] The nuclear lamins: flexibility in function
    Burke, Brian
    Stewart, Colin L.
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2013, 14 (01) : 13 - 24
  • [9] ABERRANT SPLICING IN THE LMNA GENE CAUSED BY A NOVEL MUTATION ON THE POLYPYRIMIDINE TRACT OF INTRON 5
    Carboni, Nicola
    Floris, Matteo
    Mateddu, Anna
    Porcu, Maurizio
    Marrosu, Giovanni
    Solla, Elisabetta
    Cocco, Eleonora
    Mura, Marco
    Marini, Stefano
    Maioli, Maria A.
    Piras, Rachele
    Aste, Rinaldo
    Marrosu, Maria G.
    [J]. MUSCLE & NERVE, 2011, 43 (05) : 688 - 693
  • [10] A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy
    Caux, F
    Dubosclard, E
    Lascols, O
    Buendia, B
    Chazouillères, O
    Cohen, A
    Courvalin, JC
    Laroche, L
    Capeau, J
    Vigouroux, C
    Christin-Maitre, S
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (03) : 1006 - 1013